Evidence map›Paper›PMID 37886066›Full record

ArticleFrontiers in microbiology2023

Application of multi-functional lactic acid bacteria strains in a pilot scale feta cheese production.

Christina S Kamarinou, Olga S Papadopoulou, Agapi I Doulgeraki, Chrysoula C Tassou, Alex Galanis, Nikos G Chorianopoulos, Anthoula A Argyri

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christina S KamarinouInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization-DIMITRA, Athens, Greece.
Olga S PapadopoulouInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization-DIMITRA, Athens, Greece.
Agapi I DoulgerakiLaboratory of Food Microbiology and Hygiene, Department of Food Science and Technology, Faculty of Agriculture, Forestry and Natural Environment, School of Agriculture, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Chrysoula C TassouInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization-DIMITRA, Athens, Greece.
Alex GalanisDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
Nikos G ChorianopoulosLaboratory of Microbiology and Biotechnology of Foods, School of Food and Nutritional Sciences, Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens, Greece.
Anthoula A ArgyriInstitute of Technology of Agricultural Products, Hellenic Agricultural Organization-DIMITRA, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Feta cheese is the most recognized Greek Protected Designation of Origin (PDO) product in the world. The addition of selected autochthonous lactic acid bacteria (LAB) strains to cheese milk as adjunct cultures is gaining more attention, since they can impact the nutritional, technological and sensory properties of cheeses, as well as improve the safety of the product. The aim of this study was to produce Feta cheese with enhanced quality and safety, and distinctive organoleptic characteristics by applying autochthonous lactic acid bacteria (LAB) with multi-functional properties as adjunct cultures. Feta cheeses were produced with the commercial lactococcal starter culture and the addition of 9 LAB strains (

Indexed as

autochthonous culturesfeta cheeseListeria monocytogenesmulti-functional LABorganic acidsRAPD-PCRsensory characteristics

Identifiers

PMID37886066
PMCPMC10598639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.